Loading clinical trials...
Loading clinical trials...
The use of Aquamantys during total knee arthroplasty will reduce drain output and the necessity for blood transfusions.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Montefiore Medical Center
NCT07020312 · Anterior Cruciate Ligament Reconstruction, Total Hip Arthroplasty (THA), and more
NCT05828810 · Revision Total Hip Arthroplasty (RTHA), Revision Total Knee Arthroplasty
NCT05097976 · Total Knee Arthroplasty
NCT06991231 · Post-Operative Pain, Total Knee Arthroplasty
NCT07069179 · Osteoarthritis, Osteoarthritis (OA) of the Knee, and more
Jack D. Weiler Hospital-Division of Montefiore Medical Center
The Bronx, New York
Montefiore Medical Center
The Bronx, New York
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions